Application Information

This drug has been submitted to the FDA under the reference 203756/001.

Names and composition

"COMETRIQ" is the commercial name of a drug composed of CABOZANTINIB S-MALATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
203756/001 COMETRIQ CABOZANTINIB S-MALATE CAPSULE/ORAL EQ 20MG BASE
203756/002 COMETRIQ CABOZANTINIB S-MALATE CAPSULE/ORAL EQ 80MG BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
203756/001 COMETRIQ CABOZANTINIB S-MALATE CAPSULE/ORAL EQ 20MG BASE
203756/002 COMETRIQ CABOZANTINIB S-MALATE CAPSULE/ORAL EQ 80MG BASE
208692/001 CABOMETYX CABOZANTINIB S-MALATE TABLET/ORAL EQ 20MG BASE
208692/002 CABOMETYX CABOZANTINIB S-MALATE TABLET/ORAL EQ 40MG BASE
208692/003 CABOMETYX CABOZANTINIB S-MALATE TABLET/ORAL EQ 60MG BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved